Kinase Inhibitor for Cancer Therapy
-
£27.18£28.33 -
£10.58
£12.58 -
£16.71
£17.13
Reviews & Ratings
This class of compounds is the first oral targeted therapy approved for neoplasia, and about 30 compounds have entered the market in the last five years. Kinase inhibitors include small molecules and monoclonal antibodies and are endowed with fewer side effects than classical antitumor agents.
The potential for application of this class of drugs is substantial, and this Special Issue focuses on the discovery and development of kinase inhibitors in terms of in silico studies, synthesis and identification of new compounds, drug delivery, formulation studies, and biological and pharmacokinetic evaluation. .
Frequently Bought Products
Product Queries (0)
Login Or Registerto submit your questions to seller
Other Questions
No none asked to seller yet
-
£27.18
£28.33 -
£10.58
£12.58 -
£16.71
£17.13
Bookiyos Books Solutions - Quality Books, Unbeatable Prices
Bookiyos Books Solutions is your premier online bookstore offering a vast selection of over 5 crore books. Whether you're looking for the latest releases, timeless classics, or rare finds, we have something for every reader. Our platform serves customers worldwide, including the USA, UK, and Europe, with fast delivery and easy return policies to ensure a hassle-free shopping experience. Discover daily updates, exclusive deals, and a comprehensive collection of books that cater to all your reading needs. Shop with confidence at Bookiyos, where quality books and unbeatable prices meet.
Why Choose Bookiyos?
Extensive Inventory: New, old, and rare books available.
Fast Delivery: Same or next-day shipping.
Easy Returns: Hassle-free refund and return policies.
Global Reach: Serving customers in the USA, UK, Europe, and beyond.
Daily Updates: Thousands of new titles added every day.
Join our community of book lovers and start your literary journey with Bookiyos Books Solutions today!
Subscribe to our newsletter for regular updates about Offers, Coupons & more
Follow Us
Mobile Apps
